PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F] fluoro-D-glucose, 6-deoxy-6[18F]fluoro-D-glucose, [ 1-11C]-acetate and [N-methyl-11C]-choline

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 2, 2009, Pages 144-156

  Salem, N ^a   Kuang, Y ^a   Wang, F ^a   Maclennan, G T ^b   Lee, Z ^a,b  

^a Case Western Reserve University   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Acetates; Carcinoma, hepatocellular, molecular imaging; Choline; Fluorodeoxyglucose F18; Tomography, emission computed

Indexed keywords

ACETIC ACID C 11; ACETYL COENZYME A SYNTHETASE; CHOLINE C 11; CHOLINE KINASE; FLUORODEOXYGLUCOSE F 18; GLUCOSE 6 PHOSPHATASE; HEXOKINASE; 6 DEOXY 6 FLUOROGLUCOSE; 6-DEOXY-6-FLUOROGLUCOSE; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; CHOLINE; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; METHYL CARBON 11 CHOLINE; METHYL CARBON-11 CHOLINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENZYME ACTIVITY; GENE EXPRESSION; HISTOPATHOLOGY; LIVER CARCINOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SURGICAL TECHNIQUE; VIRUS HEPATITIS; WOODCHUCK; ANIMAL; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DNA MICROARRAY; ENZYMOLOGY; LIVER CELL CARCINOMA; METABOLISM; PATHOLOGY; RADIOGRAPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTISCANNING; SCIURIDAE; STAINING;

ACETATES; ANIMALS; CARBON; CARCINOMA, HEPATOCELLULAR; CHOLINE; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; MARMOTA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAINING AND LABELING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69449089458     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cancer. World Health Organisation, 2006. p. Fact Sheet 297.
2. Merle P. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma]. Cancer Radiother 2005;9:452-7.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
4. Hepatitis B. World Health Organisation, 2000.
5. Hepatitis B - The disease. World Health Organisation, 2000.
6. Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Hornbuckle WE et al. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology 2004;127(5 Suppl 1):S283-93.
7. Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000;32:792-7.
8. Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y et al J. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995;36:1811-7.
9. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 1999;94:3314-9.
10. 18F]6FDG), a potential tracer of glucose transport. J Labelled Comp Radiopharm 2005;48:845-54.
11. Landau BR, Spring-Robinson CL, Muzic RF Jr, Rachdaoui N, Rubin D, Berridge MS et al. 6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport. Am J Physiol Endocrinol Metab 2007;293:E237-45.
12. 11C]acetate - an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot 1982;33:505-12.
13. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003;44:213-21.
14. 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001;61:110-7. (Pubitemid 32095708)
15. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990-5. (Pubitemid 28270113)
16. 11C]choline. J Nucl Med 1997;38:842-7. (Pubitemid 27251970)
17. 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest 2003;124:893-901.
18. Jager PL, Que TH, Vaalburg W, Pruim J, Elsinga P, Plukker JT. Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med 2001;28:1845-9.
19. Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K et al. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006;33:1285-9.
20. Anderson PW, Tennant BC, Lee Z. Cross-species hybridization of woodchuck hepatitis virus-induced hepatocellular carcinoma using human oligonucleotide microarrays. World J Gastroenterol 2006;12:4646-51. (Pubitemid 44269721)
21. 11C](2H3)acetate for in vivo studies of myocardium using PET. Nucl Med Biol 1994;21:1067-72.
22. Yu K, Schomisch SJ, Chandramouli V, Lee Z. Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma. Comp Biochem Physiol C Toxicol Pharmacol 2006;143:225-31.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
24. Woodnutt G, Parker DS. Rabbit liver acetyl-CoA synthetase. Biochem J 1978;175:757-9.
25. Luong A, Hannah VC, Brown MS, Goldstein JL. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem 2000;275:26458-66.
26. Wittenberg J, Rornberg A. Choline Phosphokinase. J Biol Chem 1953;202:431-44.
27. Lee Z, Muzic RF, Gagnon D. Dynamic PET for animal model of HCC. Presented at BMES, Philadelphia, 2004.
28. Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M et al. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 2003;162:1961-74.
29. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E et al. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 1993;92:486-94.
30. Pencek RR, Bertoldo A, Price J, Kelley C, Cobelli C, Kelley DE. Dose-responsive insulin regulation of glucose transport in human skeletal muscle. Am J Physiol Endocrinol Metab 2006;290: E1124-30.
31. Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995;36:1595-601.
32. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001;28:117-22.
33. Goldberg RP, Brunengraber H. Contributions of cytosolic and mitochondrial acetyl-CoA syntheses to the activation of lipogenic acetate in rat liver. Adv Exp Med Biol 1980;132:413-8.
34. Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol 2004;31:859-65.